Muutke küpsiste eelistusi

Strategies for Overcoming Chemotherapy Resistance in Cervical Cancer: From Molecular Insights to Precision Solutions, Volume 21 [Kõva köide]

Edited by (University of Pretoria, South Africa)
  • Formaat: Hardback, 216 pages, kõrgus x laius: 235x191 mm, kaal: 630 g
  • Sari: Cancer Sensitizing Agents for Chemotherapy
  • Ilmumisaeg: 24-Jan-2024
  • Kirjastus: Academic Press Inc
  • ISBN-10: 0443289859
  • ISBN-13: 9780443289859
Teised raamatud teemal:
  • Formaat: Hardback, 216 pages, kõrgus x laius: 235x191 mm, kaal: 630 g
  • Sari: Cancer Sensitizing Agents for Chemotherapy
  • Ilmumisaeg: 24-Jan-2024
  • Kirjastus: Academic Press Inc
  • ISBN-10: 0443289859
  • ISBN-13: 9780443289859
Teised raamatud teemal:
“Strategies for overcoming chemotherapy resistance in cervical cancer? highlights different strategies to reverse chemotherapy resistance in cervical cancer. The book has a strong focus on strategies to reverse chemotherapy resistance as well as strategies for early detection of the resistance, enhancing precision oncology in terms of patient care and maximizing patient management. The book also looks at virally induced resistance to chemotherapy and recommends combination therapies that can maximize the reversal of this resistance. In 10 chapters “Strategies for overcoming chemotherapy resistance in cervical cancer? not only gives an overview of cervical cancer and chemotherapy as treatment, but it also investigates resistance to chemotherapy and the treatment for resistance. It defines the treatment mechanisms, options, and limitations to beat chemotherapy resistance and the reversal of the resistance mechanisms. It gives insights into the future directions of cervical cancer treatment using epigenetic silencing, chemotherapy splicing, the involvement of MicroRNAs to chemotherapy resistance, and the application of Artificial Intelligence. This book is a valuable resource for health professionals, scientists and researchers, oncologists, virologists, health practitioners, medical and graduate students, and all those who wish to broaden their knowledge in the allied field.
1. An Overview of Cervical Cancer, chemotherapy as treatment and resistance
2. Current Treatment Options and Limitations of Cervical Cancer
3. Radiotherapy treatment resistance in cervical cancer
4. Mechanisms of Resistance in Cervical Cancer
5. Reversal of Resistance Mechanisms in Cervical Cancer
6. HPV and HIV-Associated epigenetics silencing in cervical cancer: Targets for overcoming chemoresistance
7. Splicing-Associated Chemotherapy Resistance in cervical cancer: Targeting splicing signatures
8. MicroRNAs involvement in cervical cancer chemotherapy drug resistance: restoring sensitivity to chemotherapy drugs
9. Future Directions in Cervical Cancer Treatment
10. Concluding Insights and Pathways to Overcome Cervical Chemoresistance
Zodwa Dlamini is a Professor of Molecular Oncology and the founding Director and the Executive Head of the Pan African Cancer Research Institute (PACRI) in South Africa. She is the Director of South African Medical Research Council (SAMRC) Precision Oncology Research Unit (PORU). She is the DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP). She is a member of the American Association for Cancer Research (AACR) Advisory Group on Sub-Saharan Africa. She is a member of the AACR Pathology Resources in Africa Advisory Group. Professor Dlamini is a member of the African Organisation for Research and Training in Cancer (AORTIC) Research Committee Scientific Advisory Board. She is an elected member of the Academy of Science of South Africa. Professor Dlamini is an overseas Fellow of the Royal Society of Medicine (London). She is the Associate Editor for Frontiers in Oncology: Cancer Genetics Section